**Core Concept:**
A prodrug is a pharmacologically inactive molecule that is converted into an active drug substance after administration. This conversion can occur through various mechanisms such as enzymatic or hydrolytic activation, which is mainly carried out by specific enzymes within the body. Prodrugs are designed to improve drug targeting, reduce side effects, and increase the drug's bioavailability.

**Why the Correct Answer is Right:**
The correct answer, D, refers to a prodrug's ability to bypass the liver first-pass effect and directly convert into the active drug within the target tissue or cell. This is achieved through specific enzymes within the target organ or cell, ensuring that the drug reaches its intended site of action with minimal systemic exposure and side effects.

**Why Each Wrong Option is Incorrect:**
A. This option (A) refers to a wrong concept, as prodrugs are not designed to be directly activated by the liver enzymes. Prodrugs bypass the liver first-pass effect, so this option is incorrect.

B. Although prodrugs can be activated by enzymes, this option (B) does not specify the key feature of prodrugs, which is their activation within the target tissue or cell.

C. This option (C) is incorrect because it does not address the specific advantage of prodrugs in minimizing side effects and maximizing drug targeting.

**Clinical Pearl / High-Yield Fact:**
Prodrugs can significantly improve drug efficacy, safety, and selectivity by targeting drug action to a specific organ, tissue, or cell type. This can lead to reduced side effects and improved patient outcomes. Bypassing the liver first-pass effect and activating the drug at the desired site, prodrugs can be crucial in the development of new medications for various conditions, including cancer therapy, gene therapy, and targeted drug delivery.